Embla

Embla offers an online weight loss program in Denmark with results supported by clinical studies.

Embla's coaching model is built on Acceptance and Commitment Therapy and Cognitive Behavioral Therapy. 1:1 behavioral support that addresses the root causes of weight gain — not just symptoms.

Embla uses a treat-to-target GLP-1 protocol averaging 1.08 mg/week — one-third the standard max dose. Structured tapering begins at month 16. Better outcomes, lower drug spend.

The page presents the first part of an erotic story.

The page discusses strategies to cut waste, improve outcomes, and improve weight care for people and the bottom line.

How a 400-employee self-funded employer cut GLP-1 spend by 70% without limiting access. 10-month engagement, clinical outcomes, and financial data. Free PDF.

The guide describes how self-funded employers can control GLP-1 costs without cutting coverage, using a behavior-first, low-dose, taper-to-stop approach.

The 60-minute webinar discusses how self-funded employers can control pharmacy costs while offering GLP-1 coverage.

Embla offers a no-cost GLP-1 program covered by employer Aesthetic Record.

Offer GLP-1 coverage employees want without runaway costs. Embla's coaching-led model delivers 16.7% average weight loss with 66% less medication. No plan disruption. Live in 7 days.

Embla says its 1:1 coaching addresses root causes to help people get better results with less medication while using GLP-1s.

The page covers Mounjaro prices and subsidies in Denmark and says Embla offers the medication through an online program.

The page lists Wegovy prices in Denmark from DKK 1,283, discusses subsidies, and describes Embla's low-dose program.

Embla reports average weight loss of 8% after three months regardless of starting BMI, compared with 5.8% in external research.

Embla describes a 360° weight loss approach combining established methods informed by knowledge about nutrition, exercise, medication, and mental health.

The page recounts Helle's experience trying weight loss medication through her doctor before switching to Embla.

Embla helps employers and health plans offer GLP-1 coverage without runaway costs. Behavior-first, fully managed, full carve-out.

The page explains how Embla's behavior-first GLP-1 program works, from employee enrollment to tapering, and reports average weight loss of 16.7% with no plan integration required.

Embla is a fully managed weight care benefit for self-funded employers. Behavior-first coaching, low-dose GLP-1s, and a 78.5% taper rate — with no plan integration required.

The page describes lasting weight loss in Denmark with 1:1 online coaching and low-dose weight loss medication.

Embla Health's HIPAA Notice of Privacy Practices explains how it collects, uses, and protects health information under federal privacy law.

Embla Health's privacy policy describes protections for personal and health data under HIPAA and applicable privacy law.

The company considers privacy protection important and has a privacy policy.

Embla describes transparency as a core value and provides its terms and conditions.

The company describes transparency as a core value and provides terms and conditions for joining a program.

Embla appears in Vestbee’s roundup of top European funding rounds closed in August 2023 for its Series A. Seed Capital and Inovo VC led the round.

Sep 2023 · VestbeeNews article

Embla, a Danish weight-loss app, raises a Series A round to expand its obesity clinic app into the UK market. Seed Capital and Inovo VC co-lead the financing. The funding supports the company’s planned UK expansion.

Aug 2023 · AIN.CapitalNews article